Imbio RV/LV Software vs FibriCheck
AI Verdict
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your clinical workflow involves the rapid and automated assessment of right and left ventricular dimensions from CTPA scans. This tool is ideal for radiologists and cardiologists needing to quickly risk stratify patients with suspected pulmonary embolism or other pulmonary conditions based on objective imaging biomarkers, integrating seamlessly into existing PACS environments.
View Imbio RV/LV Software →Choose FibriCheck if…
Choose FibriCheck if you require a convenient, patient-centric solution for long-term heart rhythm monitoring and arrhythmia detection using a smartphone. This app is best suited for patients who need to regularly check for conditions like Atrial Fibrillation outside of a clinical setting, with results accessible to both the patient and their healthcare provider through a dedicated portal.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | Cloud-based (private cloud). |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio RV/LV SoftwareImbio RV/LV Software offers a fully automated workflow that requires no user intervention after scan completion, integrating seamlessly with standard reading environments like PACS. This deep integration and automation significantly enhance usability for clinical professionals within their existing diagnostic processes. FibriCheck, while user-friendly for patients, requires active patient engagement.
Clinical Value
TieBoth tools offer significant clinical value in different domains. Imbio RV/LV Software provides critical, objective measurements for acute risk stratification in pulmonary embolism, directly aiding diagnostic decision-making. FibriCheck enables continuous, accessible monitoring for arrhythmias, facilitating early detection and management of chronic cardiac conditions. Their distinct but equally important contributions to patient care result in a tie.
Pricing & Value
FibriCheckFibriCheck provides transparent and detailed pricing structures for both end-users and healthcare providers, including various subscription tiers and short-term options. Imbio's pricing is described generally as subscription-based on analyses and installations, lacking the same level of public detail. This greater transparency makes FibriCheck's value proposition clearer and more easily assessed.
Enterprise Readiness
Imbio RV/LV SoftwareImbio RV/LV Software demonstrates superior enterprise readiness with its multiple deployment options, including cloud, on-premise, and integration via various partner platforms. Its explicit DICOM compliance and integration with standard PACS environments, along with third-party HIPAA certification, make it highly suitable for large-scale healthcare organizations. FibriCheck, while cloud-based with a professional portal, does not detail the same breadth of enterprise-level integration or deployment flexibility.
Innovation
FibriCheckFibriCheck leverages ubiquitous smartphone technology to provide medical-grade heart rhythm monitoring directly to patients using a simple camera-based PPG technology. This approach represents a highly accessible and disruptive innovation in remote cardiac care and patient empowerment. While Imbio's AI for automated image analysis is innovative, FibriCheck's direct patient-centric application on a common device is arguably more novel in its reach and impact.
Support & Docs
TieThe provided structured facts do not contain specific information regarding support services or documentation for either Imbio RV/LV Software or FibriCheck. Without additional verifiable data that directly compares these aspects, it is not possible to determine a winner. Therefore, this dimension is a tie.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | FibriCheck |
|---|---|---|
| Name | Imbio RV/LV Software | FibriCheck |
| Company | Imbio | Qompium nv |
| Description | AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Primary Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Family Medicine, Internal Medicine |
| Key Feature 1 | Automated measurement of right and left ventricular diameters | Smartphone camera-based PPG technology for heart rhythm measurement |
| Key Feature 2 | Calculation and reporting of RV/LV ratio | AI-powered algorithm for arrhythmia detection and analysis |
| Key Feature 3 | Artificial intelligence algorithm for ventricle identification and measurement | Healthcare professional portal/dashboard for patient monitoring |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and FibriCheck.